BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 7:36:00 PM | Browse: 1031 | Download: 1114
 |
Received |
|
2014-02-28 09:36 |
|
Peer-Review Started |
|
2014-02-28 22:35 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-04-10 23:05 |
|
Revised |
|
2014-05-01 03:10 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-07-18 13:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-07-18 14:00 |
|
Articles in Press |
|
2014-07-18 14:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-08-05 18:39 |
|
Publish the Manuscript Online |
|
2014-08-17 13:16 |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Evidence-Based Medicine |
| Article Title |
HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mariana Fernández, Matías Fabregat, Gerardo Javiel and Adriana Mimbacas |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Adriana Mimbacas, PhD, Biodiversity and Genetic Department, Instituto de Investigaciones Biológicas Clemente Estable, Avenida Italia 3318, Montevideo, CP 11600, Uruguay. amimbacas@iibce.edu.uy |
| Key Words |
Atypical diabetes; Clinical algorithm; Immunity molecular marker |
| Core Tip |
There are evidences that exists a lot of patients who were diagnosed as type 2 diabetics but present difficult management, don’t have good responses to treatment and don’t achieve the metabolic goals. We include the study of human leukocyte antigen markers typically associated whit type 1 diabetes to characterize these patients. This paper provides information about the possibility of incorporate a standardized molecular diagnosis in the clinical practice to identify complex or atypical type 2 diabetic patient.
|
| Publish Date |
2014-08-17 13:16 |
| Citation |
Fernández M, Fabregat M, Javiel G, Mimbacas A. HLA alleles may serve as a tool to discriminate atypical type 2 diabetic patients. World J Diabetes 2014; 5(5): 711-716 |
| URL |
http://www.wjgnet.com/1948-9358/full/v5/i5/711.htm |
| DOI |
http://dx.doi.org/10.4239/wjd.v5.i5.711 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
